GENERAL
Piramal Pharma Acquires Additional 40.67% Stake In Yapan Bio For ₹76 Cr
Piramal Pharma Ltd has completed the acquisition of an additional 40.67% stake in Yapan Bio Pvt Ltd for ₹76 crore, taking its total holding in the Hyderabad-based company to 74%. With the completion of the transaction on August 18, Yapan Bio has become a subsidiary of Piramal Pharma. The company is a contract development and […]
CW Bureau
·
Aug 19, 2026
GENERAL
Gland Pharma Signs MSA With Global Pharma Major For Sterile Injectables
Gland Pharma Ltd has entered into a strategic manufacturing and supply agreement (MSA) with a leading global pharmaceutical company for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for international markets. The agreement strengthens Gland Pharma’s position as an integrated end-to-end contract development and manufacturing organisation (CDMO), covering multiple products […]
CW Bureau
·
Aug 9, 2026
GENERAL
Shilpa Biologicals Commissions ADC Drug Substance Manufacturing Unit
Shilpa Biologicals Ltd, a material subsidiary of Shilpa Medicare Ltd, has commissioned a Good Manufacturing Practice (GMP)-compliant Antibody-Drug Conjugate (ADC) manufacturing facility designed to meet global regulatory standards. The facility is fully operational, with GMP qualification protocols currently underway, paving the way for commercial-scale operations. Integrated ADC capabilities With the commissioning of the facility, Shilpa […]
CW Bureau
·
Jun 24, 2026
GENERAL
Piramal Pharma Reports 9% Growth In Q4 Profit Before Exceptional Item
Global pharmaceutical company Piramal Pharma Ltd (PPL) reported a 9% increase in net profit before exceptional items at ₹167 crore for the March quarter compared with the year-ago period. However, the company posted a net loss of ₹9 crore after recognising an impairment loss of ₹176 crore related to intangible assets under development, following a […]
CW Bureau
·
Apr 29, 2026
MANUFACTURING
Tube Investments, N Govindarajan To Invest ₹100 Cr In 3xper Innoventure
Murugappa group firm Tube Investments of India Ltd (TII) has entered into a supplementary agreement with 3xper Innoventure Ltd and N Govindarajan to invest ₹75 crore by TII and ₹25 crore by Govindarajan respectively, in compulsorily convertible preference shares (CCPS) of the company. TII subsidiary 3xper operates in the contract development and manufacturing organisation (CDMO) […]
CW Bureau
·
Apr 23, 2026
